Acacia Fiber Gut Microbiome Randomized Trial Evidence Table

Structured evidence table for Acacia Fiber Gut Microbiome Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Acacia Fiber Gut Microbiome Randomized TrialAtopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disorder with a complex pathogenesis involving genetic, immune, and environmental factors.4Peng R (2026)Atopic dermatitis and the gut-skin axis: a review from dysbiosis to novel targeted therapeutic strategies.
Acacia Fiber Gut Microbiome Randomized TrialRecent advances in the research on the gut-skin axis (GSA) have shed new light on the pathophysiology of AD, highlighting the critical role of gut microbiota dysbiosis in immune regulation and inflammatory responses.4Peng R (2026)Atopic dermatitis and the gut-skin axis: a review from dysbiosis to novel targeted therapeutic strategies.
topicAcacia Fiber Gut Microbiome Randomized Trial
claimAtopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disorder with a complex pathogenesis involving genetic, immune, and environmental factors.
evidence level4
citationPeng R (2026)
sourceAtopic dermatitis and the gut-skin axis: a review from dysbiosis to novel targeted therapeutic strategies.
topicAcacia Fiber Gut Microbiome Randomized Trial
claimRecent advances in the research on the gut-skin axis (GSA) have shed new light on the pathophysiology of AD, highlighting the critical role of gut microbiota dysbiosis in immune regulation and inflammatory responses.
evidence level4
citationPeng R (2026)
sourceAtopic dermatitis and the gut-skin axis: a review from dysbiosis to novel targeted therapeutic strategies.

Source documents

  1. Atopic dermatitis and the gut-skin axis: a review from dysbiosis to novel targeted therapeutic strategies.